KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Xylem (XYL) over the last 9 years, with Q2 2025 value amounting to $4.0 million.

  • Xylem's Asset Writedowns and Impairment changed N/A to $4.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 60000.0%. This contributed to the annual value of $7.0 million for FY2024, which is 7500.0% up from last year.
  • Latest data reveals that Xylem reported Asset Writedowns and Impairment of $4.0 million as of Q2 2025.
  • Xylem's Asset Writedowns and Impairment's 5-year high stood at $12.0 million during Q3 2022, with a 5-year trough of $1.0 million in Q1 2021.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $1.0 million (2021), whereas its average is $3.1 million.
  • In the last 5 years, Xylem's Asset Writedowns and Impairment plummeted by 9166.67% in 2023 and then surged by 50000.0% in 2024.
  • Xylem's Asset Writedowns and Impairment (Quarter) stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then skyrocketed by 500.0% to $6.0 million in 2024, then crashed by 33.33% to $4.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $4.0 million for Q2 2025, versus $4.0 million for Q1 2025 and $6.0 million for Q4 2024.